C-type lectin receptors (CLRs) play central roles in immune recognition, engaging diverse endogenous and exogenous ligands through their C-type lectin-like ...

Five young Filipino researchers from different universities presented their studies as part of the 2026 NAST Talent Search ...

Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and ...

Fluorescent proteins have revolutionized science, enabling researchers to tag and visualize individual molecules in living ...

Neurobots—xenobots with neurons—show self-organized nervous systems and enhanced behaviors, revealing new insights into how ...

Cells constantly probe their environments, searching for physical cues that guide their behavior. And yet a cell's response ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...

The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...

Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gene expression, pathway activity, and cell states ...

Demyelinating diseases of the central nervous system (CNS), including multiple sclerosis (MS) and related inflammatory and degenerative disorders, represent ...

ENA101 targets DARKFOX®, a novel, cancer‑specific Dark Antigen encoded by a previously undiscovered alternative open reading frame (alt‑ORF) within FOXM1. DARKFOX was discovered and validated using ...

A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ...